Jeffrey Frick is the General Manager of HAVAS Life of China. With over 25 years of global experience within pharma, biotech start-ups and healthcare consulting, Jeff’s column will provide unique insights from China, comparing and contrasting China’s healthcare infrastructure and delivery to practices in the west - learning and considerations that will help pharma refine its strategy for success in the future. If you are interested in discussing further your portfolio or commercial strategies in China you contact him at jeffrey.frick@havasww.com.cn